Cargando…

Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers

BACKGROUND: Pharmaceuticals are an integral component of health care systems worldwide, thus, regulatory weaknesses in governance of the pharmaceutical system negatively impact health outcomes especially in developing countries [1]. Nigeria is one of a number of countries whose pharmaceutical system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garuba, Habibat A, Kohler, Jillian C, Huisman, Anna M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775729/ https://www.ncbi.nlm.nih.gov/pubmed/19874613 http://dx.doi.org/10.1186/1744-8603-5-14

Ejemplares similares

Transparency in public pharmaceutical sector: the key informants’ perceptions from a developing country
por: Esfandiari, Atefeh, et al.
Publicado: (2021)

Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
por: Grundy, Quinn, et al.
Publicado: (2022)

The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020)

Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018)

Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology
por: Sacristán, José A., et al.
Publicado: (2016)

Policy-makers’ perspectives on implementation of cross-sectoral nutrition policies, Western Pacific Region
por: Reeve, Erica, et al.
Publicado: (2021)

Exploring public perceptions of solutions to tree diseases in the UK: Implications for policy-makers
por: Jepson, Paul, et al.
Publicado: (2017)

Proofs for PLOS ONE Paper : Does Pharmaceutical Pricing Transparency Matter? Examining Brazil’s Public Procurement System
por: Kohler, Jillian Clare, et al.
Publicado: (2015)

COVID-19 in Nigeria: Is the pharmaceutical sector spared?
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2020)

Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities
por: Kamal, Susan, et al.
Publicado: (2015)

Policies and practices in Nigeria’s pharmaceutical sector: A mixed methods exploration of stakeholders’ perspectives on strategic reforms
por: Adigwe, Obi Peter
Publicado: (2023)

The link between cognitive health and neighbourhood: perceptions of the public, and of policy-makers, about problems and solutions
por: Stevens, Madeleine, et al.
Publicado: (2023)

The challenge of bridging the gap between researchers and policy makers: experiences of a Health Policy Research Group in engaging policy makers to support evidence informed policy making in Nigeria
por: Uzochukwu, Benjamin, et al.
Publicado: (2016)

Formulating Evidence-based Public Health Policies: A Guide to Policy Makers
por: Shrivastava, Saurabh R., et al.
Publicado: (2015)

A Data-informed Public Health Policy-Makers Platform
por: Brdarić, Dario, et al.
Publicado: (2020)

Perceptions, barriers and enablers of salt reduction in Malaysian out-of-home sectors (MySaltOH): from the point of view of policy-makers and food industries
por: Harun, Zaliha, et al.
Publicado: (2023)

Inputs of Iranian health system reform plan from health sector managers and policy-makers’ points of view
por: Yarmohammadian, Mohammad Hossein, et al.
Publicado: (2018)

Public Policy and Pharmaceutical Innovation
por: Grabowski, Henry G.
Publicado: (1982)

An Assessment of National Maternal and Child Health Policy-Makers’ Knowledge and Capacity for Evidence-Informed Policy-Making in Nigeria
por: Uneke, Chigozie Jesse, et al.
Publicado: (2016)

Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study
por: Ebadi Fardazar, Farbod, et al.
Publicado: (2019)

Knowledge, perception and practice of pharmaceutical waste disposal among the public in Lagos State, Nigeria
por: Adedeji-Adenola, Halimat, et al.
Publicado: (2022)

Pharmaceutical procurement among public sector procurers in CARICOM
por: Preston, Charles, et al.
Publicado: (2021)

Integrated Knowledge Translation with Public Health Policy Makers: A Scoping Review
por: Lawrence, Logan M., et al.
Publicado: (2019)

Getting Research to the Policy Table: A Qualitative Study With Public Health Researchers on Engaging With Policy Makers
por: Otten, Jennifer J., et al.
Publicado: (2015)

India’s Bhilwara COVID-19 containment policy response: Lessons for public health policy makers globally
por: Golechha, Mahaveer
Publicado: (2020)

Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda
por: Kumakech, Edward, et al.
Publicado: (2014)

Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
por: Afsharmanesh, Gita, et al.
Publicado: (2021)

REFLECTIONS FROM THE PERSPECTIVE OF A STATE POLICY MAKER
por: Knatterud, LaRhae
Publicado: (2019)

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
por: Vian, Taryn, et al.
Publicado: (2017)

Reflections from Key Policy Decision-makers on Integrated Care and the Value of Decision-maker Involvement in Research
por: Evison, Karen, et al.
Publicado: (2018)

Decision makers’ experience of participatory dynamic simulation modelling: methods for public health policy
por: Freebairn, Louise, et al.
Publicado: (2018)

Drug Consumption Rooms and Public Health Policy: Perspectives of Scottish Strategic Decision-Makers
por: Nicholls, James, et al.
Publicado: (2022)

Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector
por: Emami, Farideh, et al.
Publicado: (2022)

Pericardial Decompression Syndrome: A Case Series and Literature Review
por: Thabet, Chloe, et al.
Publicado: (2021)

Medicine Maker: An Outreach Activity for Pharmaceutical Manufacturing and Health Literacy
por: McHugh, Martin, et al.
Publicado: (2022)

Energy systems: an analysis for engineers and policy makers
por: Bailey, James E
Publicado: (1978)

Dengue: Challenges for Policy Makers and Vaccine Developers
por: Wilder-Smith, Annelies, et al.
Publicado: (2014)

Institutional roles, structures, funding and research partnerships towards evidence-informed policy-making: a multisector survey among policy-makers in Nigeria
por: Uneke, Chigozie Jesse, et al.
Publicado: (2023)

Ageing and dementia in low and middle income countries - Using research to engage with public and policy makers
por: Prince, Martin, et al.
Publicado: (2008)

Trade protectionism and the manufacturing sector: a review of border closure policy in Nigeria
por: Ajoje, Olufunke Iyabo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9p0gd628tqm4jlba6h3l3c8dn